Matches in SemOpenAlex for { <https://semopenalex.org/work/W2397054313> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2397054313 endingPage "10" @default.
- W2397054313 startingPage "605" @default.
- W2397054313 abstract "According to the data of the European Liver Transplant Registry (ELTR), liver transplantations (LTx) as a result of bile duct diseases were reported in 12.0% of cases. The aim of this study was to overview retrospective indications for operation and results of patients who underwent LTx for cholestatic diseases.725 LTx were performed between January 1989 to December 2008, including 173 (23.9%) patients with cholestatic diseases. 80 pts (46.2%) were operated because of PBC, 63 pts (36.4%) with PSC and 12 pts (6.9%) with SBC as a result of iatrogenic bile ducts injuries. In 6 pts (3.5%) Caroli's disease was the reason for transplantation and another 11 pts (6.4%) were operated because of infiltration of alveococcosis into the bile duct. Cholangiocarcinoma (CCC) developed in 6 pts with PSC (9.5%) undergoing LTx. The last patient (0.6%) of our group was operated because of mucoviscidosis. 24 pts (13.9%) underwent unsuccessful surgical treatment prior to the LTx.142 pts (82.1%) presented good outcome, but complications in postoperative period were present in 31 pts (17.9%). 8 pts (4.6%) required re-laparotomy: 6 pts due to intraperitoneal bleeding and hematoma in the first postoperative week and 2 pts due to liver abscess, 1 month and 3 months after LTx respectivelly. 4 patients (2.3%) died in the first week after LTx (septic complications, acute rejection). 5 patients with CCC died in the period of 7 to 26 months after LTx. This was caused by the recurrence of the cancer. The overall mortality was 8.1% (14 pts). 4 pts (2.3%) underwent ReLTx due to various origins--one case due to hepatic artery thrombosis, another was ischemic type biliary lesion (ITBL) and two patients due to recurrence of PBC and PSC. Cumulative 1, 5 and 10 year recurrence-free survival rates after LTx were: 94.6% / 88.7% / 72.1% in PBC group, 95.3% / 86.5% / 70.2% in PSC group and 73.9% / 69.2% / 59.3% in SBC group of patients.There is no doubt that LTx is a good and effective option of treatment for patients with cholestatic diseases. Nevertheless the long-term benefits of LTx depend on precise indications and timing of the operation." @default.
- W2397054313 created "2016-06-24" @default.
- W2397054313 creator A5012241339 @default.
- W2397054313 creator A5037907747 @default.
- W2397054313 creator A5046963138 @default.
- W2397054313 creator A5058594570 @default.
- W2397054313 creator A5075598532 @default.
- W2397054313 creator A5087124519 @default.
- W2397054313 date "2010-08-12" @default.
- W2397054313 modified "2023-09-23" @default.
- W2397054313 title "Orthotopic liver transplantation for cholestatic diseases." @default.
- W2397054313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20698235" @default.
- W2397054313 hasPublicationYear "2010" @default.
- W2397054313 type Work @default.
- W2397054313 sameAs 2397054313 @default.
- W2397054313 citedByCount "3" @default.
- W2397054313 countsByYear W23970543132016 @default.
- W2397054313 countsByYear W23970543132017 @default.
- W2397054313 crossrefType "journal-article" @default.
- W2397054313 hasAuthorship W2397054313A5012241339 @default.
- W2397054313 hasAuthorship W2397054313A5037907747 @default.
- W2397054313 hasAuthorship W2397054313A5046963138 @default.
- W2397054313 hasAuthorship W2397054313A5058594570 @default.
- W2397054313 hasAuthorship W2397054313A5075598532 @default.
- W2397054313 hasAuthorship W2397054313A5087124519 @default.
- W2397054313 hasConcept C126322002 @default.
- W2397054313 hasConcept C141071460 @default.
- W2397054313 hasConcept C2779609443 @default.
- W2397054313 hasConcept C2779777945 @default.
- W2397054313 hasConcept C2780778865 @default.
- W2397054313 hasConcept C2911091166 @default.
- W2397054313 hasConcept C71924100 @default.
- W2397054313 hasConcept C90924648 @default.
- W2397054313 hasConceptScore W2397054313C126322002 @default.
- W2397054313 hasConceptScore W2397054313C141071460 @default.
- W2397054313 hasConceptScore W2397054313C2779609443 @default.
- W2397054313 hasConceptScore W2397054313C2779777945 @default.
- W2397054313 hasConceptScore W2397054313C2780778865 @default.
- W2397054313 hasConceptScore W2397054313C2911091166 @default.
- W2397054313 hasConceptScore W2397054313C71924100 @default.
- W2397054313 hasConceptScore W2397054313C90924648 @default.
- W2397054313 hasIssue "99-100" @default.
- W2397054313 hasLocation W23970543131 @default.
- W2397054313 hasOpenAccess W2397054313 @default.
- W2397054313 hasPrimaryLocation W23970543131 @default.
- W2397054313 hasRelatedWork W155134126 @default.
- W2397054313 hasRelatedWork W1966721981 @default.
- W2397054313 hasRelatedWork W1968808671 @default.
- W2397054313 hasRelatedWork W1992023728 @default.
- W2397054313 hasRelatedWork W1994063108 @default.
- W2397054313 hasRelatedWork W2007201500 @default.
- W2397054313 hasRelatedWork W2011920823 @default.
- W2397054313 hasRelatedWork W2015736261 @default.
- W2397054313 hasRelatedWork W2018797888 @default.
- W2397054313 hasRelatedWork W2020375318 @default.
- W2397054313 hasRelatedWork W2024900502 @default.
- W2397054313 hasRelatedWork W2036296113 @default.
- W2397054313 hasRelatedWork W2047395497 @default.
- W2397054313 hasRelatedWork W2048338530 @default.
- W2397054313 hasRelatedWork W2073781342 @default.
- W2397054313 hasRelatedWork W2108159774 @default.
- W2397054313 hasRelatedWork W2144694264 @default.
- W2397054313 hasRelatedWork W2393074119 @default.
- W2397054313 hasRelatedWork W3005833655 @default.
- W2397054313 hasRelatedWork W3217516622 @default.
- W2397054313 hasVolume "57" @default.
- W2397054313 isParatext "false" @default.
- W2397054313 isRetracted "false" @default.
- W2397054313 magId "2397054313" @default.
- W2397054313 workType "article" @default.